https://www.nejm.org/doi/full/10.1056/NEJMoa2007764?query=featured_home
Sorry about the triple post
DBRPCT trial of remdesivir vs placebo in COVID-19. 1063 pts.
"Remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with Covid-19 and evidence of lower respiratory tract infection."
Sorry about the triple post
DBRPCT trial of remdesivir vs placebo in COVID-19. 1063 pts.
"Remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with Covid-19 and evidence of lower respiratory tract infection."